We at Pharmaceutical Manufacturing are always speaking with industry experts and insiders, picking their brains about issues that truly matter to the industry. Below are 12 of my favorite interviews from last year—in case you missed them the first time around. Enjoy.
In September, FDA sent a warning letter to Sichuan Pharmaceutical Co., an API manufacturer in China. The letter cited the manufacturer's failure to adequately guard against potential product cross-contamination: